Effect of vitamin D in the treatment of inflammatory bowel disease
Not Applicable
- Conditions
- inflammatory bowel disease.Crohn disease of small intestine,Ulcerative colitisk50, k51
- Registration Number
- IRCT2013122915686N1
- Lead Sponsor
- Research center of gasteroenterology and liver disease of Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Inclusion criterion:
IBD patients are diagnosed based upon clinical, endoscopic, radiological and histological criteria findings by an experienced gastroenterologist.
Exclusion criteria:
serum level of 25(OH)vitD3>30ng/ml; positive anti TTG test lab; history of hypercalcemia; kidney disorders requiring dialysis and pregnancy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 25(OH)D3 level. Timepoint: Three months after the intervention. Method of measurement: ELISA Method ( ng/ ml).;TNF alpha level. Timepoint: Three months after the intervention. Method of measurement: ELISA Method ( ng/ ml).;Activity Index. Timepoint: Three months after the intervention. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method